Clinical Trial

Identifying the Best Follow up Approach for People Who Have Had Treatment to Cure Newly Diagnosed Prostate Cancer

Study acronym: FOLLOW-UP
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Over 20,000 patients a year in the UK get surgery or radiotherapy to cure their prostate cancer. These men then undergo regular check-ups to manage potential side effects and see if cancer recurs so it can be treated quickly. The organisation of these check-ups varies across the country as it is not known which approach is best. The four different established approaches are (i) check-ups performed in hospital outpatients by the same team that provided treatment; (ii) patients seen regularly by their GP with hospital referral as necessary; (iii) planned shared care between general practice and hospital follow up; or (iv) patients supported to provide checks on themselves (self-care) and reaching out to a doctor or a nurse when required. This study will compare these options to establish which is best for patients and makes the best use of the NHS resources.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-02.
Trial Details
NCT Number NCT07264088
Lead Sponsor Imperial College London
Collaborators: London School of Hygiene and Tropical Medicine, University of Aberdeen, University of Leeds, Cardiff University, University of Sheffield, University of Southampton, University College, London, Royal Marsden NHS Foundation Trust, North Bristol NHS Trust, Cardiff and Vale University Health Board, Liverpool University Hospitals NHS Foundation Trust, National Institute for Health Research, United Kingdom
Conditions Prostate Cancer
Enrollment 100,000 participants
Start Date 2026-10
Primary Completion 2027-07 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2026-04-16